PVI
CSTL icon

Pura Vida Investments’s Castle Biosciences CSTL Stock Holding History

Pura Vida Investments’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-156,000
Closed -$10.7M – 236
2021
Q1 		$10.7M Buy
+156,000
New +$11.7M 0.3% 68

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Pura Vida Investments's CSTL Position: Q4 2024 in Review

Pura Vida Investments sold out of Castle Biosciences (CSTL) in Q4 2024, closing a stake of 62,868 shares — an estimated $1.91M sold.

Pura Vida Investments first reported a position in CSTL in Q3 2019 and held it in 4 quarters. The position peaked at $3.34M in Q2 2024. 197 funds tracked by Wall St. Rank hold CSTL as of Q4 2024.

  • Pura Vida Investments reported no remaining Castle Biosciences position as of Q4 2024 after selling out during the quarter.
  • Pura Vida Investments sold 62,868 Castle Biosciences shares in Q4 2024, an estimated $1.91M.
  • Pura Vida Investments first reported a position in Castle Biosciences in Q3 2019 and held it in 4 quarters.
  • Pura Vida Investments's Castle Biosciences position peaked at $3.34M in Q2 2024.
  • 197 funds tracked by Wall St. Rank held Castle Biosciences as of Q4 2024.

Based on Pura Vida Investments's 13F filing for Q4 2024, filed 12 Feb 2025.